View More Recent Stories

Aug 10, 2023 09:00AM Virpax Pharmaceuticals (VRPX) Files Provisional Patent Application for NSAID Formulation and Method
Aug 10, 2023 08:58AM Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method
Jul 24, 2023 07:00AM Virpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023
Jul 13, 2023 08:59AM Virpax Pharmaceuticals (VRPX) Files Provisional Patent Application for Intranasal Delivery
Jul 13, 2023 08:58AM Virpax Pharmaceuticals Files Provisional Patent Application for Intranasal Delivery
Jun 21, 2023 08:01AM Virpax Pharmaceuticals (VRPX) Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council
Jun 21, 2023 08:00AM Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council
Jun 20, 2023 04:10PM Virpax Pharmaceuticals (VRPX) Announces CFO Transition
Jun 20, 2023 04:10PM Virpax Pharmaceuticals Announces CFO Transition
Jun 13, 2023 08:58AM Virpax Pharmaceuticals to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
May 12, 2023 04:08PM Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments
May 10, 2023 07:15AM Virpax Pharmaceuticals To Present at Upcoming CB Tech Watch Seminar
May 4, 2023 08:58AM Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023
Apr 27, 2023 08:58AM Virpax Pharmaceuticals (VRPX) Engages Dr. Pardeep Gupta for Development of Probudur
Apr 27, 2023 08:58AM Virpax Pharmaceuticals Engages Dr. Pardeep Gupta to Assist in Development of Company’s Lead Asset, Probudur™
Apr 5, 2023 09:00AM Virpax Pharmaceuticals (VRPX) Reports on Progress of Envelta
Apr 5, 2023 08:58AM Virpax Reports on Progress of Envelta™
Mar 28, 2023 08:59AM Virpax Pharmaceuticals (VRPX) Appoints Barbara A. Ruskin to its Board
Mar 28, 2023 08:58AM Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors
Mar 22, 2023 08:58AM Virpax Pharmaceuticals (VRPX) Reports FY22 Results
Mar 22, 2023 08:58AM Virpax Pharmaceuticals Reports 2022 Year-End Results
Feb 13, 2023 08:58AM Virpax Pharmaceuticals (VRPX) Announces Positive Preclinical Toxicology Results in Support of Molecular Envelope Technology
Feb 13, 2023 08:58AM Virpax Announces Positive Preclinical Toxicology Results in Support of Molecular Envelope Technology (MET)
Jan 31, 2023 09:00AM Virpax Pharmaceuticals (VRPX) Engages New England Investors to Direct Licensing Strategy for Envelta in China
Jan 31, 2023 08:58AM Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China
View More Recent Stories